Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<p>Semax can be administered either via <strong>intranasal spray</strong> or <strong>subcutaneous injection</strong>, depending on preference and application goals:</p>
<ul>
<li><strong>Standard Dosage:</strong> 200–600 mcg daily</li>
<li><strong>Cycle Length:</strong> 10 to 20 days</li>
<li><strong>Maintenance:</strong> 2–3x/week for ongoing cognitive support</li>
</ul>
<p>When combined with other <a href="https://www.dragonpharma.net/peptides-414">nootropic peptides</a> such as <a href="https://www.dragonpharma.net/peptides-414/selank-45651">Selank</a>, the synergistic benefits may further enhance memory retention and mood regulation.</p>
<h3>Who Benefits from Semax?</h3>
<p>Semax is commonly used by individuals seeking improved:</p>
<ul>
<li>Focus and mental clarity</li>
<li>Learning ability and working memory</li>
<li>Stress resilience and recovery from mental fatigue</li>
</ul>
<p>Its fast-acting effects and minimal side effect profile make it ideal for students, high-performing professionals, and individuals recovering from cognitive strain.</p>
<h3>Adverse Effects & Considerations</h3>
<p>Semax is widely regarded as safe, with few known side effects. Mild nasal irritation (when administered intranasally), headaches, or agitation have been reported in rare cases. Most users tolerate it well, especially at standard dosages.</p>
<p>Incorporating it into a neuroregenerative plan alongside Lion's Mane, Alpha-GPC, or nootropic cycles may enhance results. For those stacking Semax with other compounds, our <a href="/">trusted Dragon Pharma source</a> offers complete peptide stacks and lab-tested products.</p>
<h3>Example of Semax Cycle</h3>
<ul>
<li>Week 1–2: 200 mcg/day (intro phase)</li>
<li>Week 3–4: 400–600 mcg/day (cognitive boost phase)</li>
<li>Week 5+: 250–500 mcg 2–3x/week (maintenance phase)</li>
</ul>
</section>
</div>
Technical Details
Peptide Type
Synthetic Linear Heptapeptide
Peptide Sequence
Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
Peptide Length
7 Amino-Acid Residues
Terminal Form
H-MEHFPGP-OH
Structural Origin
ACTH(4–7) + Pro-Gly-Pro Extension
Molecular Formula
C₃₇H₅₁N₉O₁₀S
Molecular Weight
813.9 g/mol
Research Profile
Neuroregulatory Signaling
Research Status
Experimental / Regionally Used
